Differential methylation in rare ophthalmic disorders: a systematic review protocol

Abstract Background Rare ophthalmic conditions often cause degenerative vision loss which leads to loss of independence, ability to work and ultimately quality life. Differential methylation is an epigenomic marker that is a feature of several diseases, including eye conditions. This review will aim...

Full description

Bibliographic Details
Main Authors: Katie Kerr, Helen McAneney, Amy Jayne McKnight
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Systematic Reviews
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13643-019-0999-3
_version_ 1819228185263341568
author Katie Kerr
Helen McAneney
Amy Jayne McKnight
author_facet Katie Kerr
Helen McAneney
Amy Jayne McKnight
author_sort Katie Kerr
collection DOAJ
description Abstract Background Rare ophthalmic conditions often cause degenerative vision loss which leads to loss of independence, ability to work and ultimately quality life. Differential methylation is an epigenomic marker that is a feature of several diseases, including eye conditions. This review will aim to elucidate the extent to which differential methylation has been identified in rare ophthalmic conditions. Methods A systematic review will be conducted of articles found in the electronic databases MEDLINE, EMBASE, PubMed and Cochrane Library of Systematic Reviews. Grey literature databases GreyLit and OpenGrey will be searched for relevant unpublished sources. Reference lists of articles which meet eligibility criteria will also be screened for forward and reverse citations. Eligibility criteria will include quantitative articles published, before July 2018, written in English and featuring analysis of differential methylation in rare ophthalmic disorders. Studies will be screened firstly by title, abstract and keywords and then by full text for any remaining sources, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data extraction of key characteristics will be completed using customised forms. Methodological rigour will be assessed using customised forms modelled on the Joanna Briggs Institute critical appraisal forms. Discussion This systematic review will enable us to identify if differential methylation can be used to characterise rare ophthalmic disease, which could have crucial implications for improving the accuracy and speed of diagnosis, identifying novel therapeutic targets to reduce or prevent vision loss and overall improving understanding of rare ophthalmic disease. Systematic review registration PROSPERO CRD42018094231
first_indexed 2024-12-23T10:53:15Z
format Article
id doaj.art-450da332bf544754a819cab4788cc814
institution Directory Open Access Journal
issn 2046-4053
language English
last_indexed 2024-12-23T10:53:15Z
publishDate 2019-04-01
publisher BMC
record_format Article
series Systematic Reviews
spelling doaj.art-450da332bf544754a819cab4788cc8142022-12-21T17:49:51ZengBMCSystematic Reviews2046-40532019-04-01811410.1186/s13643-019-0999-3Differential methylation in rare ophthalmic disorders: a systematic review protocolKatie Kerr0Helen McAneney1Amy Jayne McKnight2Centre for Public Health, Queen’s University BelfastCentre for Public Health, Queen’s University BelfastCentre for Public Health, Queen’s University BelfastAbstract Background Rare ophthalmic conditions often cause degenerative vision loss which leads to loss of independence, ability to work and ultimately quality life. Differential methylation is an epigenomic marker that is a feature of several diseases, including eye conditions. This review will aim to elucidate the extent to which differential methylation has been identified in rare ophthalmic conditions. Methods A systematic review will be conducted of articles found in the electronic databases MEDLINE, EMBASE, PubMed and Cochrane Library of Systematic Reviews. Grey literature databases GreyLit and OpenGrey will be searched for relevant unpublished sources. Reference lists of articles which meet eligibility criteria will also be screened for forward and reverse citations. Eligibility criteria will include quantitative articles published, before July 2018, written in English and featuring analysis of differential methylation in rare ophthalmic disorders. Studies will be screened firstly by title, abstract and keywords and then by full text for any remaining sources, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data extraction of key characteristics will be completed using customised forms. Methodological rigour will be assessed using customised forms modelled on the Joanna Briggs Institute critical appraisal forms. Discussion This systematic review will enable us to identify if differential methylation can be used to characterise rare ophthalmic disease, which could have crucial implications for improving the accuracy and speed of diagnosis, identifying novel therapeutic targets to reduce or prevent vision loss and overall improving understanding of rare ophthalmic disease. Systematic review registration PROSPERO CRD42018094231http://link.springer.com/article/10.1186/s13643-019-0999-3AssociationEpigeneticsEpigenomicsEyeInheritedMethylation
spellingShingle Katie Kerr
Helen McAneney
Amy Jayne McKnight
Differential methylation in rare ophthalmic disorders: a systematic review protocol
Systematic Reviews
Association
Epigenetics
Epigenomics
Eye
Inherited
Methylation
title Differential methylation in rare ophthalmic disorders: a systematic review protocol
title_full Differential methylation in rare ophthalmic disorders: a systematic review protocol
title_fullStr Differential methylation in rare ophthalmic disorders: a systematic review protocol
title_full_unstemmed Differential methylation in rare ophthalmic disorders: a systematic review protocol
title_short Differential methylation in rare ophthalmic disorders: a systematic review protocol
title_sort differential methylation in rare ophthalmic disorders a systematic review protocol
topic Association
Epigenetics
Epigenomics
Eye
Inherited
Methylation
url http://link.springer.com/article/10.1186/s13643-019-0999-3
work_keys_str_mv AT katiekerr differentialmethylationinrareophthalmicdisordersasystematicreviewprotocol
AT helenmcaneney differentialmethylationinrareophthalmicdisordersasystematicreviewprotocol
AT amyjaynemcknight differentialmethylationinrareophthalmicdisordersasystematicreviewprotocol